Dermatology Times

🚨🚨 BREAKING NEWS: L'Oréal has issued a voluntary recall of benzoyl peroxide products over benzene concerns. The recall includes La Roche-Posay's Effaclar Duo product. Stay tuned for more updates from Dermatology Times throughout the day. 🖇 Read more: https://lnkd.in/epGGVb_z 🎥 Watch the latest exclusive interview with Christopher Bunick, MD, PhD, on next steps: https://lnkd.in/gnXVF9eJ

📰 FROM OUR PUBLICATION: Mohs surgery is the gold standard for treating dermatofibrosarcoma protuberans (DFSP), a rare and slow-growing tumor. It offers higher recurrence-free survival compared to traditional excision, especially in delicate areas, by ensuring complete tumor clearance and tissue conservation. 🖇 Read more from Nicole A. Negbenebor, MD, FAAD: https://lnkd.in/g2_YhNde

📚 STUDY FINDINGS: A novel monopolar radiofrequency device effectively reduced mild to moderate wrinkles around the eyes and cheeks after just one session. Significant aesthetic improvements were seen at 4 and 16 weeks, with minimal pain and no severe adverse effects. 🖇 Read more: https://lnkd.in/gD_VEzbG

✍️📰 SUNDAY CROSSWORD: Test your knowledge of key words and terms associated with Dermatology Times news from the previous week. 🖇 Read more: https://lnkd.in/gVd-ysru

🎥 How do JAK inhibitors fit into the evolving AD treatment landscape? Experts discuss patient selection, safety considerations, and clinical decision-making. Watch now: https://ow.ly/EwAK50VcbZA

📰 FROM OUR PUBLICATION: Valerie Harvey, MD, MPH, FAAD, shared key insights on pigmentary disorders like melasma and hyperpigmentation, which disproportionately affect women, especially those with darker skin. Treatment gaps, lack of access, and mental health impacts highlight the need for more inclusive, effective care and research. 🖇 Read more: https://lnkd.in/gME9erwn

📈 NEW DATA: A survey on seborrheic dermatitis revealed dissatisfaction with current treatments, with patients and providers seeking more effective, time-saving options. Both groups emphasize the need for therapies that fit easily into routines, considering skin tone and cultural preferences. 🖇 Read more: https://lnkd.in/gQDais8b

💡 EXPERT INSIGHTS: A recent Dermatology Times Case-Based Roundtable, led by Joel Schlessinger, MD, highlighted challenges in managing advanced basal cell carcinoma (BCC) and squamous cell carcinoma (CSCC). Emerging treatments like HPIs and checkpoint inhibitors offer promise for complex cases. 🖇 Read more: https://lnkd.in/gj-rrqs3

📚 STUDY FINDINGS: Thermus thermophilus fermentation extract (TTFE) shows promise for treating androgenic alopecia, boosting hair density by 96.88% and reducing inflammation. With benefits like improved scalp hydration and reduced sebum, it may offer a safer alternative to traditional treatments. 🖇 Read more: https://lnkd.in/g6XPnfjv

💡 EXPERT INSIGHTS: Warren Winkelman, MD, PhD, spoke about new promising results for zasocitinib, an investigational oral treatment for psoriasis, at #AAD2025 "I think it's important for us to remember that every patient is different. Patients are individuals, we study them in populations, but patients are first and foremost people," Winkelman said. 🖇 Read more: https://lnkd.in/gs5Wrmrs